ResearcherWuhan Union HospitalActive in the last 2 years
Tao Peng
Matched on ORCID iD 0000-0001-6020-9066; OpenAlex author ID A5047117416. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 2
- Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. Last author DOI 10.1016/j.intimp.2023.111407↗
- Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling. Last author DOI 10.1186/s10020-021-00300-8↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yao Guo · 2 shared papers, 2021–2024 · strength 0.43
- Paper Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resis… DOI 10.1016/j.intimp.2023.111407↗
- Paper Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via … DOI 10.1186/s10020-021-00300-8↗
- Taoyu Chen · 1 shared paper, 2024 · strength 0.26
- Jing Cui · 1 shared paper, 2021 · strength 0.17
- Heshui Wu · 1 shared paper, 2021 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.